[Cardiac and renal protective effects of SGLT2 inhibitors]

Rev Med Interne. 2024 Jun;45(6):323-326. doi: 10.1016/j.revmed.2024.05.026.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cardiovascular Diseases / prevention & control
  • Diabetes Mellitus, Type 2* / drug therapy
  • Diabetic Nephropathies / prevention & control
  • Heart / drug effects
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Kidney / drug effects
  • Kidney / pathology
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Hypoglycemic Agents
  • Sodium-Glucose Transporter 2 Inhibitors